Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13014-022-02081-8/MediaObjects/13014_2022_2081_Fig2_HTML.png)
Trends in receipt of direct operation and preoperative neoadjuvant therapy for mid and low LARC between January 2015 and December 2021. A. The proportion of direct operation after diagnosis; B. The proportion of neoadjuvant therapy (nT); C. The proportion of neoadjuvant chemotherapy (CT) alone; D. The proportion of neoadjuvant short-course radiotherapy (SCRT); E. The proportion of neoadjuvant long-course chemoradiotherapy (LCRT);